rs145833100

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_152743.4(BRAT1):​c.2041G>A​(p.Glu681Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,611,408 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E681A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00080 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:6

Conservation

PhyloP100: -2.25

Publications

1 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047898293).
BP6
Variant 7-2538494-C-T is Benign according to our data. Variant chr7-2538494-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377362.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152743.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
NM_152743.4
MANE Select
c.2041G>Ap.Glu681Lys
missense
Exon 14 of 14NP_689956.2Q6PJG6-1
BRAT1
NM_001350626.2
c.2221G>Ap.Glu741Lys
missense
Exon 14 of 14NP_001337555.1
BRAT1
NM_001350627.2
c.1516G>Ap.Glu506Lys
missense
Exon 13 of 13NP_001337556.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
ENST00000340611.9
TSL:1 MANE Select
c.2041G>Ap.Glu681Lys
missense
Exon 14 of 14ENSP00000339637.4Q6PJG6-1
BRAT1
ENST00000890463.1
c.2278G>Ap.Glu760Lys
missense
Exon 16 of 16ENSP00000560522.1
BRAT1
ENST00000917322.1
c.2275G>Ap.Glu759Lys
missense
Exon 16 of 16ENSP00000587381.1

Frequencies

GnomAD3 genomes
AF:
0.000802
AC:
122
AN:
152208
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00135
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000791
AC:
195
AN:
246472
AF XY:
0.000812
show subpopulations
Gnomad AFR exome
AF:
0.000127
Gnomad AMR exome
AF:
0.000841
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000950
Gnomad NFE exome
AF:
0.00117
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00150
AC:
2190
AN:
1459082
Hom.:
3
Cov.:
65
AF XY:
0.00146
AC XY:
1057
AN XY:
725950
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33472
American (AMR)
AF:
0.000716
AC:
32
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86238
European-Finnish (FIN)
AF:
0.000785
AC:
40
AN:
50936
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
0.00180
AC:
1998
AN:
1111804
Other (OTH)
AF:
0.00147
AC:
89
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
167
335
502
670
837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000801
AC:
122
AN:
152326
Hom.:
0
Cov.:
34
AF XY:
0.000765
AC XY:
57
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41580
American (AMR)
AF:
0.000784
AC:
12
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00135
AC:
92
AN:
68010
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000938
Hom.:
0
Bravo
AF:
0.000884
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.000758
AC:
92
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00136
EpiControl
AF:
0.00124

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
not provided (4)
-
-
2
Neonatal-onset encephalopathy with rigidity and seizures (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
Intellectual disability (1)
-
-
1
Neonatal-onset encephalopathy with rigidity and seizures;C4748032:Neurodevelopmental disorder with cerebellar atrophy and with or without seizures (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
2.3
DANN
Benign
0.52
DEOGEN2
Benign
0.00066
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.68
T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.0048
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.36
N
PhyloP100
-2.2
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.16
N
REVEL
Benign
0.0030
Sift
Benign
0.88
T
Sift4G
Benign
0.94
T
Polyphen
0.0010
B
Vest4
0.084
MVP
0.048
MPC
0.050
ClinPred
0.00041
T
GERP RS
-5.8
Varity_R
0.013
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145833100; hg19: chr7-2578128; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.